Skip to content
Screener

NuSkin Enterprises NUS Balance Sheet Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$189.64M-28.2%$198.65M-2.5%$238.63M+27.7%$251.79M+10.6%$264.16M+17.8%
$1.74M+43.9%$1.75M-82.1%$1.21M-89.1%$1.21M-88.0%$1.21M-86.0%
$48.9M-18.1%$45.01M-20.4%$39.54M-22.1%$48.89M-28.9%$59.7M-16.6%
$191.5M+6.2%$178.6M-5.4%$178.64M-6.1%$178.53M-27.9%$180.38M-26.1%
$508.15M-11.1%$522.89M-0.4%$547.7M+1.7%$548.14M-16.1%$571.55M-12.7%
$379.55M+1.4%$381.61M+0.4%$377.17M-0.6%$375.28M-8.6%$374.21M-9.2%
$4.75M-94.3%$83.63M0.0%$83.63M0.0%$83.63M-16.3%$83.63M-16.3%
$37.88M-17.5%$39.29M-17.4%$42.61M-42.6%$44.2M-48.2%$45.94M-48.1%
$1.12B-22.3%$1.38B-1.1%$1.41B-4.3%$1.42B-10.0%$1.44B-9.0%
$37.71M+31.2%$28.82M-14.2%$26.18M-24.9%$28.52M-12.9%$28.73M-20.9%
$6.3M-14.9%$6.2M-17.3%$7.2M-7.7%$7.3M-36.5%$7.4M-37.3%
$20M-42.9%$20M0.0%$20M-33.3%$20M-66.7%$35M+16.7%
$256.35M-9.7%$257M-1.3%$263.73M-11.1%$254.44M-25.0%$283.91M-8.0%
$193.66M-9.5%$203.59M-6.9%$204.19M-43.8%$209.04M-44.0%$213.9M-50.1%
$578.79M-11.8%$582.71M-8.6%$600.07M-26.6%$624.61M-28.7%$655.94M-27.1%
500M0.0%500M0.0%500M+549,351%500M0.0%500M0.0%
$1.61B-12.4%$1.86B+2.4%$1.86B+8.7%$1.85B+5.6%$1.83B+5.1%
$542.74M-31.1%$794.09M+5.3%$805.24M+23.6%$799.8M+13.1%$787.75M+14.8%
$1.12B-22.3%$1.38B-1.1%$1.41B-4.3%$1.42B-10.0%$1.44B-9.0%

FAQ

What are NuSkin Enterprises's total assets?
NuSkin Enterprises (NUS) holds $1.1B in total assets, down 22.3% year over year.
How much debt does NuSkin Enterprises have?
NuSkin Enterprises carries $288.1M in total debt against $542.7M of shareholders' equity, a debt-to-equity ratio of 0.53.
How much cash does NuSkin Enterprises have?
NuSkin Enterprises holds $189.6M in cash and equivalents.
Can NuSkin Enterprises cover its short-term obligations?
Its current ratio is 1.98 — current assets exceed current liabilities.
Where does NuSkin Enterprises's balance sheet data come from?
Every line is extracted from NuSkin Enterprises's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.